S

Sophia Genetics SA
NASDAQ:SOPH

Watchlist Manager
Sophia Genetics SA
NASDAQ:SOPH
Watchlist
Price: 4.6 USD -5.54% Market Closed
Market Cap: 310.9m USD
Section:
 

Relative Value

The Relative Value of one SOPH stock under the Base Case scenario is 4.39 USD. Compared to the current market price of 4.6 USD, Sophia Genetics SA is Overvalued by 5%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SOPH Relative Value
Base Case
4.39 USD
Overvaluation 5%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

4.2
P/S
P/S
Price to Sales
4.2
vs History
56
vs Industry
36
Median 3Y
4.1
Median 5Y
4.5
Industry
2.3
Forward
4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-3.6
Median 5Y
-3.7
Industry
22.5
Forward
-4
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-5.5
Median 5Y
-5.6
Industry
14.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-5.3
Median 5Y
-5.4
Industry
21.5
More Details
3.6
P/B
P/B
Price to Book Value
3.6
vs History
9
vs Industry
45
Median 3Y
2.1
Median 5Y
2.1
Industry
2.2
More Details
3.6
EV/S
EV/S
Enterprise Value to Sales
3.6
vs History
25
vs Industry
46
Median 3Y
2.7
Median 5Y
2.7
Industry
2.6
Forward
3.5
More Details
5.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.4
vs History
25
vs Industry
57
Median 3Y
4
Median 5Y
4
Industry
5.2
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-2.9
Industry
11.9
Forward
-6.4
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-2.6
Industry
16.9
Forward
-3.8
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-4
Median 5Y
-4
Industry
14.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-3.4
Median 5Y
-3.4
Industry
18.7
More Details
3.6
EV/IC
EV/IC
Enterprise Value to IC
3.6
vs History
21
vs Industry
39
Median 3Y
2.3
Median 5Y
2.5
Industry
1.9
More Details

Multiples Across Competitors

SOPH Competitors Multiples
Sophia Genetics SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Sophia Genetics SA
NASDAQ:SOPH
307.4m USD 4.2 -4.1 -4.5 -3.9
US
Veeva Systems Inc
NYSE:VEEV
38.1B USD 12.4 44.3 33.9 35.4
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
24.7B AUD 112.2 214.7 148.5 148.5
JP
M3 Inc
TSE:2413
1.5T JPY 4.8 36.2 18.1 21.7
US
Doximity Inc
NYSE:DOCS
8.5B USD 13.7 33.5 29.4 30.8
US
Waystar Holding Corp
NASDAQ:WAY
5.3B USD 5.1 47.8 16 25.1
SE
Sectra AB
STO:SECT B
53.3B SEK 25 90.9 -127.9 -127.9
US
Inspire Medical Systems Inc
NYSE:INSP
4.1B USD 4.6 91.6 76.2 102.4
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
270.3B INR 10.1 55.6 34.6 40.4
US
Vocera Communications Inc
F:V00
2.4B EUR 11.9 -328.6 268.4 4 296.7
P/E Multiple
Earnings Growth PEG
CH
S
Sophia Genetics SA
NASDAQ:SOPH
Average P/E: 74.2
Negative Multiple: -4.1 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
44.3
32%
1.4
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
214.7
32%
6.7
JP
M3 Inc
TSE:2413
36.2
16%
2.3
US
Doximity Inc
NYSE:DOCS
33.5
18%
1.9
US
W
Waystar Holding Corp
NASDAQ:WAY
47.8
N/A N/A
SE
Sectra AB
STO:SECT B
90.9
28%
3.2
US
Inspire Medical Systems Inc
NYSE:INSP
91.6
13%
7
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
55.6
30%
1.9
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328.6 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CH
S
Sophia Genetics SA
NASDAQ:SOPH
Average EV/EBITDA: 71.9
Negative Multiple: -4.5 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
33.9
39%
0.9
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
148.5
32%
4.6
JP
M3 Inc
TSE:2413
18.1
14%
1.3
US
Doximity Inc
NYSE:DOCS
29.4
23%
1.3
US
W
Waystar Holding Corp
NASDAQ:WAY
16
24%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -127.9 N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
76.2
80%
1
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
34.6
24%
1.4
US
V
Vocera Communications Inc
F:V00
268.4
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CH
S
Sophia Genetics SA
NASDAQ:SOPH
Average EV/EBIT: 527.1
Negative Multiple: -3.9 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
35.4
39%
0.9
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
148.5
31%
4.8
JP
M3 Inc
TSE:2413
21.7
N/A N/A
US
Doximity Inc
NYSE:DOCS
30.8
25%
1.2
US
W
Waystar Holding Corp
NASDAQ:WAY
25.1
56%
0.4
SE
Sectra AB
STO:SECT B
Negative Multiple: -127.9 N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
102.4
34%
3
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
40.4
27%
1.5
US
V
Vocera Communications Inc
F:V00
4 296.7
N/A N/A

See Also

Summary
SOPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
SOPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SOPH stock valuation using valuation multiples.
Wall Street Estimates
SOPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SOPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 301,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.